Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
ClinicalTrials.gov study NCT01415882. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03267888. IPD Sharing: NO. Countries: 1. Publications: 1.
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02958969. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01302392. IPD Sharing: Not stated. Countries: 19. Publications: 2.
Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02509052. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma
ClinicalTrials.gov study NCT00747123. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00916058. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04484623. IPD Sharing: NO. Countries: 18. Publications: 4.
Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
ClinicalTrials.gov study NCT01615029. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01169337. IPD Sharing: Not stated. Countries: 3. Publications: 1.
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT01827137. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03318861. IPD Sharing: NO. Countries: 1. Publications: 1.
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma
ClinicalTrials.gov study NCT03168438. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients
ClinicalTrials.gov study NCT02514239. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05704049. IPD Sharing: YES. Countries: 7. Publications: 1.
Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00153920. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT01897714. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00420849. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03290950. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov study NCT02969837. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.